<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>DHANUKA on Financial Report Insights</title>
    <link>https://reports.muthu.co/tags/dhanuka/</link>
    <description>Recent content in DHANUKA on Financial Report Insights</description>
    <generator>Hugo</generator>
    <language>en-us</language>
    <lastBuildDate>Mon, 19 May 2025 19:14:58 +0000</lastBuildDate>
    <atom:link href="https://reports.muthu.co/tags/dhanuka/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Dhanuka Agritech Ltd - May 2025 Earnings Call Transcript Analysis</title>
      <link>https://reports.muthu.co/posts/dhanuka-agritech-ltd---may-2025-earnings-call-transcript-analysis/</link>
      <pubDate>Mon, 19 May 2025 19:14:58 +0000</pubDate>
      <guid>https://reports.muthu.co/posts/dhanuka-agritech-ltd---may-2025-earnings-call-transcript-analysis/</guid>
      <description>&lt;h2 class=&#34;heading&#34; id=&#34;earnings-call-transcript-analysis-report&#34;&gt;&#xA;  Earnings Call Transcript Analysis Report&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#earnings-call-transcript-analysis-report&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h2&gt;&#xA;&lt;h2 class=&#34;heading&#34; id=&#34;financial-performance&#34;&gt;&#xA;  Financial Performance&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#financial-performance&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h2&gt;&#xA;&lt;h3 class=&#34;heading&#34; id=&#34;key-financial-metrics--comparison&#34;&gt;&#xA;  Key Financial Metrics &amp;amp; Comparison&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#key-financial-metrics--comparison&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h3&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;&lt;strong&gt;Revenue from Operations (Q4 FY25):&lt;/strong&gt; Rs. 442.02 crores, an increase of 20.01% YoY.&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;Revenue from Operations (FY25):&lt;/strong&gt; Rs. 2035.15 crores, an increase of 15.73% YoY.&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;EBITDA (Q4 FY25):&lt;/strong&gt; Stated as Rs. 1095.75 crores (this seems to be a typo in the transcript, likely meant Rs. 109.57 crores if Q4 EBITDA margin is 24.83% on Rs. 442.02 cr revenue. Assuming it&amp;rsquo;s Rs. 109.57 crores, up 37.03% YoY).&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;EBITDA (FY25):&lt;/strong&gt; Rs. 416.61 crores, up 27.23% YoY.&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;EBITDA Margin (Q4 FY25):&lt;/strong&gt; 24.83%, improved from 21.75% in Q4 FY24.&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;EBITDA Margin (FY25):&lt;/strong&gt; 20.47%, improved from 18.62% in FY24 (an improvement of 180 bps).&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;Profit After Tax (PAT) (Q4 FY25):&lt;/strong&gt; Rs. 75.5 crores, up 27.94% YoY.&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;Profit After Tax (PAT) (FY25):&lt;/strong&gt; Rs. 296.96 crores, up 24.2% YoY.&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;PAT Margin (Q4 FY25):&lt;/strong&gt; 17.08%, improved from 16.02% in Q4 FY24.&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;PAT Margin (FY25):&lt;/strong&gt; 14.59%, improved from 13.6% in FY24 (an increase of 99 bps).&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h3 class=&#34;heading&#34; id=&#34;revised-guidanceforecasts&#34;&gt;&#xA;  Revised Guidance/Forecasts&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#revised-guidanceforecasts&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h3&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;&lt;strong&gt;FY25 EBITDA Margin Guidance:&lt;/strong&gt; Initial guidance was a 100 bps reduction, revised mid-year to 100 bps improvement, and delivered 180 bps improvement.&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;FY26 Revenue Growth Guidance:&lt;/strong&gt; &amp;ldquo;higher double digit growth&amp;rdquo;.&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;FY26 EBITDA Margin Guidance:&lt;/strong&gt; Expected to &amp;ldquo;remain on similar lines as this year [FY25]&amp;rdquo;.&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;FY26 Gross Margin Guidance:&lt;/strong&gt; Expecting a &amp;ldquo;hit of around 100 basis point in the year 25-26&amp;rdquo;.&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h3 class=&#34;heading&#34; id=&#34;areas-of-growth&#34;&gt;&#xA;  Areas of Growth&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#areas-of-growth&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h3&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;Overall revenue growth driven by existing product portfolio and increased B2B sales.&lt;/li&gt;&#xA;&lt;li&gt;Significant improvement in EBITDA and PAT margins.&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;Volume vs. Value Growth (Q4 FY25):&lt;/strong&gt; Volume growth ~19%, Value growth 20%.&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;Volume vs. Value Growth (FY25):&lt;/strong&gt; Volume growth ~18% (300 bps higher than value growth of ~15%).&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h3 class=&#34;heading&#34; id=&#34;dividend--buyback&#34;&gt;&#xA;  Dividend &amp;amp; Buyback&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#dividend--buyback&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h3&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;&lt;strong&gt;Dividend:&lt;/strong&gt; Recommended 100% dividend (Rs. 2 per equity share), absorbing Rs. 9.02 crores.&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;Buyback:&lt;/strong&gt; Completed buyback of 5 lakh shares at Rs. 2000 per share in Q2 FY25.&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h3 class=&#34;heading&#34; id=&#34;segment-performance&#34;&gt;&#xA;  Segment Performance&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#segment-performance&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h3&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;&lt;strong&gt;Zone-wise Turnover (Q4 FY25):&lt;/strong&gt; North 34%, East 12%, West 20%, South 34%.&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;Product Category-wise Turnover (Q4 FY25):&lt;/strong&gt; Insecticides 38%, Fungicides 13%, Herbicides 32%, Others 17%.&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;B2B Sales (FY25):&lt;/strong&gt; ~9% of total revenue (Rs. 40 crores from Dahej included), up from ~4% in FY24.&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h2 class=&#34;heading&#34; id=&#34;strategic-initiatives--business-updates&#34;&gt;&#xA;  Strategic Initiatives &amp;amp; Business Updates&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#strategic-initiatives--business-updates&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h2&gt;&#xA;&lt;h3 class=&#34;heading&#34; id=&#34;major-strategic-announcements&#34;&gt;&#xA;  Major Strategic Announcements&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#major-strategic-announcements&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h3&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;Acquisition of international rights for two fungicide molecules (iprovalicarb and triadimenol) from Bayer AG, Germany.&lt;/li&gt;&#xA;&lt;li&gt;This acquisition provides presence in over 20 countries, marking a step towards becoming a global agrochemical player.&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h3 class=&#34;heading&#34; id=&#34;new-products-services-or-markets-discussed&#34;&gt;&#xA;  New Products, Services, or Markets Discussed&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#new-products-services-or-markets-discussed&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h3&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;&lt;strong&gt;Bayer Molecules:&lt;/strong&gt; Expected to contribute Rs. 110 crores revenue in FY26 (including India brand sales and international sales). Distribution takeover from Bayer starting October, India launch in May.&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;New Fungicide from Dahej:&lt;/strong&gt; A non-synthetic pyrethroid fungicide to be manufactured at Dahej, revenue expected from Q2 FY26 (approx. Rs. 10 crores in FY26).&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;Planned Launches (FY26):&lt;/strong&gt; Paddy herbicide (from Japan HoCo chemicals) in May, Japanese fungicide (from Nissan Chemicals) in next quarter. Grapes fungicide late next quarter.&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h3 class=&#34;heading&#34; id=&#34;significant-operational-changes&#34;&gt;&#xA;  Significant Operational Changes&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#significant-operational-changes&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h3&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;Aggressively increased presence in corporate (B2B) sales in the Indian market.&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h4 class=&#34;heading&#34; id=&#34;dahej-facility&#34;&gt;&#xA;  Dahej Facility&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#dahej-facility&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h4&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;FY25 Revenue: Rs. 40 crores.&lt;/li&gt;&#xA;&lt;li&gt;FY25 EBITDA: Negative Rs. 14 crores.&lt;/li&gt;&#xA;&lt;li&gt;FY26 Expected Revenue: Rs. 60 crores (including Rs. 10 crores from new fungicide).&lt;/li&gt;&#xA;&lt;li&gt;FY26 Expected EBITDA: Similar negative lines as FY25.&lt;/li&gt;&#xA;&lt;li&gt;Current Capacity Utilization (FY25): ~25%. Expected FY26: ~35%.&lt;/li&gt;&#xA;&lt;li&gt;EBITDA Breakeven Utilization: ~70-80%.&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h3 class=&#34;heading&#34; id=&#34;ongoing-or-completed-projects&#34;&gt;&#xA;  Ongoing or Completed Projects&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#ongoing-or-completed-projects&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h3&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;Strong R&amp;amp;D division with NABL-accredited lab, focusing on new product registration and development.&lt;/li&gt;&#xA;&lt;li&gt;International collaborations with 10 leading global agrochemical companies.&lt;/li&gt;&#xA;&lt;li&gt;Investment in process research yielding good results with more products in the pipeline.&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h2 class=&#34;heading&#34; id=&#34;market--competitive-landscape&#34;&gt;&#xA;  Market &amp;amp; Competitive Landscape&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#market--competitive-landscape&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h2&gt;&#xA;&lt;h3 class=&#34;heading&#34; id=&#34;industry-trends&#34;&gt;&#xA;  Industry Trends&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#industry-trends&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h3&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;Positive monsoon forecast (105% of LPA by IMD and SKYNET) creating positive sentiment for growers.&lt;/li&gt;&#xA;&lt;li&gt;India emerging as a key supply chain point for agrochemicals, especially with negative sentiments around China and trade wars.&lt;/li&gt;&#xA;&lt;li&gt;Increasing price trend in raw materials noted in the last quarter of FY25.&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h3 class=&#34;heading&#34; id=&#34;competitive-positioning-statements&#34;&gt;&#xA;  Competitive Positioning Statements&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#competitive-positioning-statements&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h3&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;&amp;ldquo;Dhanuka is working with the vision of transforming India through agriculture.&amp;rdquo;&lt;/li&gt;&#xA;&lt;li&gt;&amp;ldquo;Dhanuka&amp;rsquo;s, key focus has been on introduction of novel chemistry and extensive product development, distinguishing us from the rest of the industry.&amp;rdquo;&lt;/li&gt;&#xA;&lt;li&gt;Journey &amp;ldquo;from an Indian leader to a global agrochemical player&amp;rdquo; via Bayer molecules acquisition.&lt;/li&gt;&#xA;&lt;li&gt;Focus on differentiated products on the manufacturing side, similar to brand strategy.&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h3 class=&#34;heading&#34; id=&#34;market-challenges-or-opportunities-mentioned&#34;&gt;&#xA;  Market Challenges or Opportunities Mentioned&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#market-challenges-or-opportunities-mentioned&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h3&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;&lt;strong&gt;Opportunity:&lt;/strong&gt; International market presents a &amp;ldquo;great opportunity for Dhanuka to expand our operations beyond the boundaries of India.&amp;rdquo;&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;Challenge:&lt;/strong&gt; International agrochemical market currently &amp;ldquo;behaving the way it is behaving&amp;rdquo; (implying some sluggishness).&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;Opportunity:&lt;/strong&gt; Brazil market for one of the acquired Bayer products has high entry barriers, which Dhanuka expects to maintain.&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h3 class=&#34;heading&#34; id=&#34;market-share-or-positioning&#34;&gt;&#xA;  Market Share or Positioning&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#market-share-or-positioning&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h3&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;Pan-India presence reaching over 10 million farmers.&lt;/li&gt;&#xA;&lt;li&gt;Network of ~6500 distributors and 80,000 retailers.&lt;/li&gt;&#xA;&lt;li&gt;B2B sales ramp-up is a strategic call to build channel for future products from Dahej and R&amp;amp;D.&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h2 class=&#34;heading&#34; id=&#34;risk-factors--challenges&#34;&gt;&#xA;  Risk Factors &amp;amp; Challenges&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#risk-factors--challenges&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h2&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;&lt;strong&gt;Dahej Facility Profitability:&lt;/strong&gt; Currently running at a negative EBITDA of Rs. 14 crores (FY25) and expected to remain similar in FY26. Needs 70-80% utilization to break even.&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;Raw Material Prices:&lt;/strong&gt; Increasing trend in raw material prices, which the company intends to pass on to customers. This is expected to cause a 100 bps hit on gross margins in FY26.&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;International Market Conditions:&lt;/strong&gt; Acknowledged that the &amp;ldquo;international market obviously, is behaving the way it is behaving,&amp;rdquo; implying some headwinds.&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;Trade Receivables:&lt;/strong&gt; &amp;ldquo;trade receivables have gone up significantly.&amp;rdquo; Management stated they are in line with expectations and will come down in Q1.&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h2 class=&#34;heading&#34; id=&#34;forward-looking-statements&#34;&gt;&#xA;  Forward-Looking Statements&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#forward-looking-statements&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h2&gt;&#xA;&lt;h3 class=&#34;heading&#34; id=&#34;outlook-and-future-projections&#34;&gt;&#xA;  Outlook and Future Projections&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#outlook-and-future-projections&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h3&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;FY26 Revenue Growth: &amp;ldquo;higher double digit growth&amp;rdquo;.&lt;/li&gt;&#xA;&lt;li&gt;FY26 EBITDA Margin: &amp;ldquo;expected to remain on similar lines as this year [FY25]&amp;rdquo;.&lt;/li&gt;&#xA;&lt;li&gt;FY26 Gross Margin: Expected &amp;ldquo;hit of around 100 basis point&amp;rdquo;.&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h3 class=&#34;heading&#34; id=&#34;commitments-or-targets-set-by-management&#34;&gt;&#xA;  Commitments or Targets Set by Management&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#commitments-or-targets-set-by-management&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h3&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;Dahej Facility Revenue (FY26): Rs. 60 crores.&lt;/li&gt;&#xA;&lt;li&gt;Revenue from acquired Bayer molecules (FY26): Rs. 110 crores.&lt;/li&gt;&#xA;&lt;li&gt;Net economic benefit/royalty from Bayer arrangement (FY26): Rs. 15-20 crores.&lt;/li&gt;&#xA;&lt;li&gt;Overall Export Revenue (FY26, excluding Bayer products): Expected Rs. 60 crores (up from Rs. 30&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&#xA;&#xA;&#xA;&lt;div class=&#34;button-container&#34;&gt;    &#xA;    &lt;a href=&#34;https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0377d95b-b87a-4993-92f7-70fb42b51159.pdf&#34; target=&#34;_blank&#34; class=&#34;report-button&#34;&gt;&#xA;      &lt;i class=&#34;fas fa-file-pdf&#34;&gt;&lt;/i&gt; Download Transcript&#xA;    &lt;/a&gt;&#xA;&lt;/div&gt;</description>
    </item>
    <item>
      <title>Dhanuka Agritech Ltd:Annual Report 2023-24 Analysis</title>
      <link>https://reports.muthu.co/posts/dhanuka-agritech-ltdannual-report-2023-24-analysis/</link>
      <pubDate>Wed, 10 Jul 2024 18:28:22 +0000</pubDate>
      <guid>https://reports.muthu.co/posts/dhanuka-agritech-ltdannual-report-2023-24-analysis/</guid>
      <description>&lt;h2 class=&#34;heading&#34; id=&#34;dhanuka-agritech-ltd-a-comprehensive-overview&#34;&gt;&#xA;  Dhanuka Agritech Ltd.: A Comprehensive Overview&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#dhanuka-agritech-ltd-a-comprehensive-overview&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h2&gt;&#xA;&lt;h3 class=&#34;heading&#34; id=&#34;about-the-company&#34;&gt;&#xA;  About the Company&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#about-the-company&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h3&gt;&#xA;&lt;p&gt;&lt;strong&gt;Year of Establishment and Founding History:&lt;/strong&gt; Dhanuka Agritech Ltd. was established in 1985 by Mr. R.G. Agarwal.&lt;/p&gt;&#xA;&lt;p&gt;&lt;strong&gt;Headquarters Location:&lt;/strong&gt; The company is headquartered in Gurugram, Haryana, India.&lt;/p&gt;&#xA;&lt;p&gt;&lt;strong&gt;Company Vision and Mission:&lt;/strong&gt; Their vision is to be a leading Indian agri-input company by providing quality products and services to enhance farm productivity and profitability. Their mission is to empower farmers by providing innovative and sustainable agricultural solutions.&lt;/p&gt;</description>
    </item>
  </channel>
</rss>
